Advertisement
Advertisement

CYCN

CYCN logo

Cyclerion Therapeutics, Inc. Common Stock

3.52
USD
Sponsored
-0.06
-1.54%
Aug 11, 11:26 UTC -4
Open

Cyclerion Therapeutics, Inc. Common Stock Profile

About

Cyclerion Therapeutics Inc. is a clinical-stage biopharmaceutical company harnessing the power of sGC pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases. The company's product pipeline consists of Olinciguat, Praliciguat and IW-6463 which are in clinical stage. Cyclerion Therapeutics Inc. is based in Cambridge, United States.

Info & Links

CEO

Regina Graul

Headquarters

245 FIRST STREET,18TH FLOOR
CAMBRIDGE, MA 02142, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.cyclerion.com

Auditor

Ernst & Young LLP

Share holders

70

Employees

1

Cyclerion Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

16.50M

Enterprise Value

15.11M

Enterprise Value/EBITDA(ttm)

-2.21

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

8.06

Price to Book(mrq)

3.29

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

50.00%

Operating Margin(ttm)

-170.11%

Profit Margin(ttm)

-47.37%

Return on Equity(ttm)

-87.96%

Return on Invested Capital(ttm)

-100.31%

Return on Assets(ttm)

-74.86%

Income Statement

Revenue(ttm)

1.90M

Revenue Per Share(ttm)

0.41

Gross Profit(ttm)

1.90M

EBITDA(ttm)3

-6.82M

Net Income Available to Common(ttm)

-6.71M

Diluted EPS(ttm)

-1.66

Share Statistics

Beta (5Y Monthly)

1.76

52-Week Change

53.85%

S&P 500 52-Week Change

21.37%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

4.68M

Dividend Yield

0.00%

Float4

3.08M

% Held by Insiders

34.30%

% Held by Institutions

75.62%

Balance Sheet

Total Cash(mrq)

1.39M

Total Cash Per Share(mrq)

0.30

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

0.82%

Quick Ratio(mrq)

0.82%

Book Value Per Share(mrq)

1.20

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.61

Free Cash Flow(ytd)

-2.67M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement